Multiple Sclerosis
WASHINGTON - Federal health regulators have approved the first pill to treat the underlying causes of multiple sclerosis, a debilitating nervous system disorder that has traditionally been treated with injectable drugs.
HAWTHORNE, N.Y. - Biotechnology company Acorda Therapeutics Inc.
SILVER SPRING, Md. - Federal health experts said Thursday a first-of-a-kind multiple sclerosis drug from Novartis is safe and effective for controlling tremors and other symptoms of the debilitating disease.
SILVER SPRING, Md. - Federal health experts say a first-of-a-kind multiple sclerosis drug from Novartis is effective at controlling tremors, concentration problems and other symptoms of the debilitating disease.
WASHINGTON - Federal health regulators said Tuesday a highly anticipated Novartis drug for multiple sclerosis appears effective but carries a number of side effects, including lung and eye problems.
